Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

DSpace Repositorium (Manakin basiert)

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Autor(en): Eigentler, Thomas; Thomas, Ioannis; Samoylenko, Igor; Erdmann, Michael; Heinzerling, Lucie; Ochsenreither, Sebastian; Krauss, Juergen; Oberoi, Arjun; Robert, Caroline; Lebbe, Celeste; Martin-Liberal, Juan; Koch, Lukas; Richtig, Erika; Terheyden, Patrick; Weishaupt, Carsten; Mohr, Peter; Semiletova, Yulia; Perez, Casilda Llacer; Brossart, Peter; Bauernfeind, Franz Georg; Fluck, Michael; Poltoratskiy, Artem; Sekacheva, Marina; Soria, Ainara; Schmitt-Bormann, Beate; Gonzalez, Marina; Hess, Jana; Wengenmayer, Peter; Seibel, Tobias; Koch, Sven D.; Quintini, Gianluca; Codo, Paula; Falk, Martin; Schoenborn-Kellenberger, Oliver; Gnad-Vogt, Ulrike
Tübinger Autor(en):
Thomas, Ioannis
Erschienen in: Journal For Immunotherapy of Cancer (2025), Bd. 13 (2), Article e009352
Verlagsangabe: London : Bmj Publishing Group
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1136/jitc-2024-009352
ISSN: 2051-1426
DDC-Klassifikation: 570 - Biowissenschaften, Biologie
610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: